Favourites   Have ideas?  Sign in / Register

Positive:

Negative:


Hepatitis segment

ABUS Arbutus Biopharma Corporation - Common Stock 11.06% 11.06% 0 + Biopharma, Medicine, Hepatitis


Last highlighted: #ABUS SEC report: Arbutus Biopharma Corp Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Arbutus Biopharma Corp -- SEC File Number 211148337
+ My List
ALGS Aligos Therapeutics, Inc. - Common stock 6.84% down 7.34% -0.5 + Medicine, Hepatitis


Last highlighted: #ALGS SEC report: Aligos Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Aligos Therapeutics, Inc. -- SEC File Number 211148130
+ My List
COCP Cocrystal Pharma, Inc. - Common Stock 7.21% up 5.41% 1.8 + Medicine, Hepatitis, COVID, Covid (fighting)

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.